References
- Bibby M.C., Double J.A., Loadman P.M., Duke C.V. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. Journal of the National Cancer Institute 1989; 81: 216–220
- Corbett T.H., Bissery M.C., Wozniak A., Plowman J., Polin L., Tapazoglou E., Dieckman J., Valeriote F. Activity of flavone acetic acid (NSC-347512) against solid tumors of mice. Investigations on New Drugs 1986; 4: 207–220
- Evelhoch J.L., Bissery M.C., Chabot G.G., Simpson N.E., McCoy C.L., Heilbrun L.K., Corbett T.H. Flavone acetic acid (NSC34512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Research 1988; 48: 4749–4755
- Finlay G.J., Smith G.P., Fray L.M., Baguley B.C. Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect. Journal of the National Cancer Institute 1988; 80: 241–245
- Hill S.A., Williams K.B., Denekamp J. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. European Journal of Cancer and Clinical Oncology 1989; 25: 1419–1424
- Horsman M.R., Christensen K.L., Overgaard J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. International Journal of Hyperthermia 1989; 5: 123–136
- Overgaard J., Nielsen O.S. The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia. Annals of the New York Academy of Science 1980; 335: 254–280
- Smith G.P., Calveley S.B., Smith M.J., Baguley B.C. Flavone acetic acid (NSC347512) induced haemorrhagic necrosis of mouse colon 26 and 28 tumours. European Journal of Cancer and Clinical Oncology 1987; 23: 1209–1211
- Sun J.R., Brown J.M. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. Cancer Research 1989; 49: 5664–5670